高风险头颈部皮肤鳞状细胞癌患者淋巴结转移检测中基线临床检查与超声成像诊断准确性的评估
这项诊断研究基于荷兰鹿特丹一家三级转诊医院2015年1月1日至2017年12月31日的233例患者(246个高风险头颈部皮肤鳞状细胞癌肿瘤)的回顾性队列,评估基线临床检查和超声对淋巴结转移的诊断准确性。结果显示,基线超声较单纯临床检查对淋巴结转移的检测更敏感;在基线临床检查阴性时,超声检测淋巴结转移的敏感性高,但需结合高假阳性率评估。
要点
- 在233例患者(246个肿瘤)中,基线细胞学确诊20处转移,6个月随访再检出2处,转移率为9%。
- 临床检查敏感性50%,特异性96%,阳性预测值55%,阴性预测值95%。
- 超声总敏感性91%、特异性78%、阳性预测值29%、阴性预测值99%;临床检查阴性者中超声敏感性82%、特异性79%。
核心结论
- 在高风险头颈部皮肤鳞状细胞癌患者队列中,基线超声检测淋巴结转移较单纯临床检查更敏感;基线临床检查阴性时,超声检测淋巴结转移敏感性高,但该敏感性应结合高假阳性率评估。
研究设计与样本
- 诊断研究,基于2015年1月1日至2017年12月31日在荷兰鹿特丹Erasmus Medical Center Cancer Institute(皮肤癌三级转诊医院)接受淋巴结临床检查和基线超声成像的所有高风险头颈部皮肤鳞状细胞癌患者的回顾性队列,共233例患者、246个肿瘤。
- 以细针穿刺细胞学活检和每例患者6个月随访作为参考标准;数据分析时间为2020年10月13日至2021年9月29日。
主要发现
- 233例患者(176例男性[75.5%];中位年龄79.1岁[IQR 71.5-83.7岁];未收集种族和族裔数据)共246个高风险头颈部皮肤鳞状细胞癌肿瘤,基线细胞学确诊20处转移,6个月随访期间检出2处转移,转移率为9%。
- 临床检查敏感性为50%(95%CI 28%-72%),特异性为96%(95%CI 93%-98%),阳性预测值为55%(95%CI 36%-72%),阴性预测值为95%(95%CI 93%-97%)。
- 在总队列中,超声敏感性为91%(95%CI 71%-99%),特异性为78%(95%CI 72%-83%),阳性预测值为29%(95%CI 23%-35%),阴性预测值为99%(95%CI 96%-100%)。
- 在基线临床检查结果阴性的患者组中,11处转移中的9处由超声检出,敏感性为82%(95%CI 48%-98%);特异性为79%(95%CI 73%-84%),阳性预测值为17%(95%CI 12%-23%),阴性预测值为99%(95%CI 96%-100%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients with cutaneous squamous cell carcinoma (SCC) of the head and neck may develop lymph node metastasis; therefore, additional workup of the regional lymph nodes in these patients should be considered. However, there is uncertainty regarding the value of baseline ultrasonographic imaging in addition to clinical examination for the detection of metastasis. OBJECTIVE: To assess the diagnostic accuracy of clinical examination and baseline ultrasonography for the detection of metastasis among patients with high-risk cutaneous SCC of the head and neck and to assess the accuracy of ultrasonography when baseline clinical examination produces negative results. DESIGN, SETTING, AND PARTICIPANTS: This diagnostic study was conducted among a retrospective cohort of 233 patients with 246 high-risk cutaneous SCC tumors of the head and neck. The study included all patients with high-risk cutaneous SCC of the head and neck who received clinical examination and baseline ultrasonographic imaging of their lymph nodes at the Erasmus Medical Center Cancer Institute, a tertiary referral hospital for patients with skin cancer in Rotterdam, the Netherlands, between January 1, 2015, and December 31, 2017. Data were analyzed from October 13, 2020, to September 29, 2021. MAIN OUTCOMES AND MEASURES: Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. Fine-needle aspiration cytologic biopsy and 6 months of follow-up per patient were used as the reference standards. RESULTS: Among 233 patients (176 men [75.5%]; median age, 79.1 years [IQR, 71.5-83.7 years]; data on race and ethnicity were not collected) with 246 high-risk cutaneous SCC tumors of the head and neck, 20 metastases were cytologically confirmed at baseline, and 2 metastases were detected during 6 months of follow-up, yielding a 9% metastasis rate. The sensitivity of clinical examination was 50% (95% CI, 28%-72%), and the specificity was 96% (95% CI, 93%-98%). The PPV and NPV were 55% (95% CI, 36%-72%) and 95% (95% CI, 93%-97%), respectively. In the total cohort, ultrasonography had a sensitivity of 91% (95% CI, 71%-99%) and a specificity of 78% (95% CI, 72%-83%), with a PPV of 29% (95% CI, 23%-35%) and an NPV of 99% (95% CI, 96%-100%). In the group of patients with negative results at baseline clinical examination, 9 of 11 metastases were detected by ultrasonography, with 82% sensitivity (95% CI, 48%-98%); specificity was 79% (95% CI, 73%-84%), PPV was 17% (95% CI, 12%-23%), and NPV was 99% (95% CI, 96%-100%). CONCLUSIONS AND RELEVANCE: In this diagnostic study, among a cohort of patients with high-risk cutaneous SCC of the head and neck, baseline ultrasonography was more sensitive than clinical examination alone for the detection of lymph node metastasis. In the setting of a negative result at baseline clinical examination, ultrasonography had high sensitivity for detecting nodal metastases, but this sensitivity should be evaluated against the high rate of false-positive findings.
引用
- Tokez S, Koekelkoren FHJ, Baatenburg de Jong RJ, et al. Assessment of the Diagnostic Accuracy of Baseline Clinical Examination and Ultrasonographic Imaging for the Detection of Lymph Node Metastasis in Patients With High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Dermatol. 2022. PMID: 34964807. doi:10.1001/jamadermatol.2021.4990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。